Infectious complications following allogeneic stem cell transplantation: reduced-intensity vs. myeloablative

S-H Kim1, S Y Kee, D-G Lee

  • 1Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

Abstract

Insights

Reduced-intensity conditioning (RIC) in allogeneic stem cell transplantation (allo-SCT) lowers overall infection rates and delays infection onset. However, RIC does not reduce infection-related mortality compared to myeloablative conditioning (MAC).

Area of Science:

  • Hematology
  • Transplantation Immunology
  • Infectious Diseases

Background:

  • Reduced-intensity conditioning (RIC) in allogeneic stem cell transplantation (allo-SCT) is associated with lower toxicity.
  • The impact of RIC on infection risk and infection-related mortality (IRM) after allo-SCT is not well-established.

Purpose of the Study:

  • To compare the incidence and timing of infectious episodes and IRM between patients undergoing allo-SCT with RIC versus myeloablative conditioning (MAC).

Main Methods:

  • Retrospective analysis of infectious episodes and IRM in 81 RIC and 150 MAC allo-SCT recipients.
  • Comparison of infection rates, onset timing, and specific infection types between RIC and MAC groups.

Main Results:

  • Patients in the RIC group had a lower cumulative incidence of any infection (72% vs. 87%, P = 0.007) and delayed infection onset (P = 0.012).
  • Bacteremia was less frequent in the RIC group (5% vs. 14%, P = 0.044).
  • No significant differences were observed in cytomegalovirus reactivation, herpes zoster, hemorrhagic cystitis, invasive fungal infections, relapse-free survival, or IRM between RIC and MAC groups.

Conclusions:

  • While RIC reduces overall infection rates and delays onset, specific severe infections and IRM are comparable to MAC.
  • Allo-SCT recipients with RIC require vigilant monitoring and infection management strategies similar to those for MAC recipients, particularly post-engraftment.

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...